母亲吸烟,代谢基因多态化和婴儿出生体重
Xiaobin Wang1, Barry Zuckerman, Colleen Pearson
1Department of Pediatrics, Boston University School of Medicine and Boston Medical Center, 91 E Concord St, Maternity 4, Boston, MA 02118, USA. xbwang@bu.edu
JAMA
|January 12, 2002
概括
在CYP1A1和GSTT1中的母性遗传变异会影响香烟烟雾如何影响婴儿出生体重. 特定的基因型会放大吸烟对胎儿生长的负面影响.
科学领域:
- 遗传学 是一个遗传学.
- 环境健康 环境健康
- 产科 产科 产科 产科 产科
背景情况:
- 对香烟烟雾和不良怀孕结果的遗传易感性尚不清楚.
- 研究基因与环境的相互作用对于了解妊娠并发症至关重要.
研究的目的:
- 检查CYP1A1和GSTT1的母亲遗传变异是否会改变吸烟和婴儿出生体重之间的关联.
- 为了确定影响胎儿发育的特定基因环境相互作用.
主要方法:
- 一项涉及741名母亲 (174名吸烟者,567名非吸烟者) 的病例控制研究.
- 分析了与母亲吸烟状况和CYP1A1/GSTT1基因型相关的出生体重和妊娠期.
- 病例包括早产或低出生体重的婴儿;对照组是满期,非低出生体重的婴儿.
主要成果:
- 母亲吸烟与降低出生体重 (377克) 有关.
- CYP1A1 (Aa/aa) 和GSTT1 (缺席) 基因型显著放大了吸烟者的出生体重减少 (高达1285g).
- 在非吸烟者中没有观察到这些基因型的独立不良影响.
结论:
- 母亲CYP1A1和GSTT1基因型显著改变了吸烟对婴儿出生体重的影响.
- 这些发现表明,特定的代谢基因与环境暴露 (如怀孕期间吸烟) 之间存在关键相互作用.
相关概念视频
Animal Mitochondrial Genetics
Among all the organelles in an animal cell, only mitochondria have their own independent genomes. Animal mitochondrial DNA is a double-stranded, closed-circular molecule with around 20,000 base pairs. Mitochondrial DNA is unique in that one of its two strands, the heavy, or H, -strand is guanine rich, whereas the complementary strand is cytosine rich and called the light, or L, -strand. Compared to nuclear DNA, mitochondrial DNA has a very low percentage of non-coding regions and is marked by...
Genomic Imprinting and Inheritance
Diploid organisms inherit genetic material through chromosomes from both parents. Copies of the same gene are known as alleles. In most cases, both alleles are simultaneously expressed and allow various cellular processes to function optimally. If one of the alleles is missing or mutated, the expression of the other allele can compensate; however, this is not true for all genes.
The expression of some genes depends on which parent passed the gene to the offspring, through a phenomenon known as...
The expression of some genes depends on which parent passed the gene to the offspring, through a phenomenon known as...
Background and Environment Affect Phenotype
Although the genetic makeup of an organism plays a major role in determining the phenotype, there are also several environmental factors, such as temperature, oxygen availability, presence of mutagens, that can alter an organism’s phenotype.
An example of how genetic background affects phenotype can be seen in horses. The Extension gene in horses is responsible for their coat color. A wild-type gene (EE) produces black pigment in the coat, while a mutant gene (ee) produces red pigment. A...
An example of how genetic background affects phenotype can be seen in horses. The Extension gene in horses is responsible for their coat color. A wild-type gene (EE) produces black pigment in the coat, while a mutant gene (ee) produces red pigment. A...
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
Pharmacogenetics of Drug Metabolism: Overview
Genetic polymorphism in drug metabolism is crucial to the inter-individual variability observed in drug responses. Drug metabolism primarily involves the chemical modification of drugs and other xenobiotics to enhance their elimination by increasing their polarity. Two main classes of enzymes mediate this biotransformation process: Phase I enzymes, primarily cytochrome P450s, catalyze oxidation and reduction reactions, while other enzymes, such as esterases, mediate hydrolysis, and Phase II...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...


